Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 58

1.

Magnetic Resonance Parkinsonism Index for evaluating disease progression rate in progressive supranuclear palsy: A longitudinal 2-year study.

Quattrone A, Morelli M, Quattrone A, Vescio B, Nigro S, Arabia G, Nisticò R, Novellino F, Salsone M, Arcuri P, Luca A, Mazzuca A, Alessio C, Rocca F, Caracciolo M.

Parkinsonism Relat Disord. 2020 Feb 1;72:1-6. doi: 10.1016/j.parkreldis.2020.01.019. [Epub ahead of print]

PMID:
32036297
2.

Morphological and ultrastructural features of Mesocestoides corti during in vitro differentiation from larva to adult worm.

Camargo de Lima J, Caracciolo ME, Lima LR, Lopes-Torres EJ, Ferreira HB.

Clin Microbiol Infect. 2019 Oct 14. pii: S1198-743X(19)30532-4. doi: 10.1016/j.cmi.2019.10.005. [Epub ahead of print] No abstract available.

PMID:
31622666
3.

Left Atrial Dynamics During Exercise in Mitral Regurgitation of Primary and Secondary Origin: Pathophysiological Insights by Exercise Echocardiography Combined With Gas Exchange Analysis.

Sugimoto T, Bandera F, Generati G, Alfonzetti E, Barletta M, Losito M, Labate V, Rovida M, Caracciolo M, Pappone C, Ciconte G, Guazzi M.

JACC Cardiovasc Imaging. 2020 Jan;13(1 Pt 1):25-40. doi: 10.1016/j.jcmg.2018.12.031. Epub 2019 Mar 13.

PMID:
30878440
4.

Imaging counterpart of postural instability and vertical ocular dysfunction in patients with PSP: A multimodal MRI study.

Quattrone A, Caligiuri ME, Morelli M, Nigro S, Vescio B, Arabia G, Nicoletti G, Nisticò R, Salsone M, Novellino F, Barbagallo G, Vaccaro MG, Sabatini U, Vescio V, Stanà C, Rocca F, Caracciolo M, Quattrone A.

Parkinsonism Relat Disord. 2019 Jun;63:124-130. doi: 10.1016/j.parkreldis.2019.02.022. Epub 2019 Feb 19.

PMID:
30803901
5.

Refining initial diagnosis of Parkinson's disease after follow-up: A 4-year prospective clinical and magnetic resonance imaging study.

Quattrone A, Morelli M, Vescio B, Nigro S, Le Piane E, Sabatini U, Caracciolo M, Vescio V, Quattrone A, Barbagallo G, Stanà C, Nicoletti G, Arabia G, Nisticò R, Novellino F, Salsone M.

Mov Disord. 2019 Apr;34(4):487-495. doi: 10.1002/mds.27621. Epub 2019 Feb 13.

6.

In vivo evidence for decreased scyllo-inositol levels in the supplementary motor area of patients with Progressive Supranuclear Palsy: A proton MR spectroscopy study.

Barbagallo G, Morelli M, Quattrone A, Chiriaco C, Vaccaro MG, Gullà D, Rocca F, Caracciolo M, Novellino F, Sarica A, Arabia G, Sabatini U, Quattrone A.

Parkinsonism Relat Disord. 2019 May;62:185-191. doi: 10.1016/j.parkreldis.2018.12.008. Epub 2018 Dec 11.

PMID:
30558837
7.

A new MR imaging index for differentiation of progressive supranuclear palsy-parkinsonism from Parkinson's disease.

Quattrone A, Morelli M, Nigro S, Quattrone A, Vescio B, Arabia G, Nicoletti G, Nisticò R, Salsone M, Novellino F, Barbagallo G, Le Piane E, Pugliese P, Bosco D, Vaccaro MG, Chiriaco C, Sabatini U, Vescio V, Stanà C, Rocca F, Gullà D, Caracciolo M.

Parkinsonism Relat Disord. 2018 Sep;54:3-8. doi: 10.1016/j.parkreldis.2018.07.016. Epub 2018 Jul 25.

PMID:
30068492
8.

Increased glutamate + glutamine levels in the thalamus of patients with essential tremor: A preliminary proton MR spectroscopic study.

Barbagallo G, Arabia G, Novellino F, Nisticò R, Salsone M, Morelli M, Rocca F, Quattrone A, Caracciolo M, Sabatini U, Cherubini A, Quattrone A.

Parkinsonism Relat Disord. 2018 Feb;47:57-63. doi: 10.1016/j.parkreldis.2017.11.345. Epub 2017 Nov 28.

PMID:
29203059
9.

Thalamic neurometabolic alterations in tremulous Parkinson's disease: A preliminary proton MR spectroscopy study.

Barbagallo G, Arabia G, Morelli M, Nisticò R, Novellino F, Salsone M, Rocca F, Quattrone A, Caracciolo M, Sabatini U, Cherubini A, Quattrone A.

Parkinsonism Relat Disord. 2017 Oct;43:78-84. doi: 10.1016/j.parkreldis.2017.07.028. Epub 2017 Jul 28.

PMID:
28774469
10.

Increased cerebellar gray matter volume in head chefs.

Cerasa A, Sarica A, Martino I, Fabbricatore C, Tomaiuolo F, Rocca F, Caracciolo M, Quattrone A.

PLoS One. 2017 Feb 9;12(2):e0171457. doi: 10.1371/journal.pone.0171457. eCollection 2017.

11.

MR parkinsonism index predicts vertical supranuclear gaze palsy in patients with PSP-parkinsonism.

Quattrone A, Morelli M, Williams DR, Vescio B, Arabia G, Nigro S, Nicoletti G, Salsone M, Novellino F, Nisticò R, Pucci F, Chiriaco C, Pugliese P, Bosco D, Caracciolo M.

Neurology. 2016 Sep 20;87(12):1266-73. doi: 10.1212/WNL.0000000000003125. Epub 2016 Aug 24.

12.

The movement time analyser task investigated with functional near infrared spectroscopy: an ecologic approach for measuring hemodynamic response in the motor system.

Vasta R, Cerasa A, Gramigna V, Augimeri A, Olivadese G, Pellegrino G, Martino I, Machado A, Cai Z, Caracciolo M, Grova C, Quattrone A.

Aging Clin Exp Res. 2017 Apr;29(2):311-318. doi: 10.1007/s40520-016-0566-x. Epub 2016 Apr 7.

PMID:
27055849
13.

The neuroanatomical correlates of anxiety in a healthy population: differences between the State-Trait Anxiety Inventory and the Hamilton Anxiety Rating Scale.

Donzuso G, Cerasa A, Gioia MC, Caracciolo M, Quattrone A.

Brain Behav. 2014 Jul;4(4):504-14. doi: 10.1002/brb3.232. Epub 2014 Jun 18.

14.

Detection of Simkania negevensis in cell culture by using a monoclonal antibody.

Donati M, Di Paolo M, Avanzi S, Di Francesco A, Fiani N, Favaroni A, Caracciolo M, Cevenini R.

New Microbiol. 2013 Jan;36(1):85-8. Epub 2013 Jan 1.

15.

Ejection fraction change and coronary artery disease severity: a vasodilator contrast stress-echocardiography study.

Squeri A, Gaibazzi N, Reverberi C, Caracciolo MM, Ardissino D, Gherli T.

J Am Soc Echocardiogr. 2012 Apr;25(4):454-9. doi: 10.1016/j.echo.2011.12.009. Epub 2012 Jan 11.

PMID:
22243999
16.

Presenilin enhancer-2 gene: identification of a novel promoter mutation in a patient with early-onset familial Alzheimer's disease.

Andreoli V, Trecroci F, La Russa A, Cittadella R, Liguori M, Spadafora P, Caracciolo M, Di Palma G, Colica C, Gambardella A, Quattrone A.

Alzheimers Dement. 2011 Nov;7(6):574-8. doi: 10.1016/j.jalz.2011.02.010.

PMID:
22055974
17.

Management of patients with recently implanted coronary stents on dual antiplatelet therapy who need to undergo major surgery.

Savonitto S, Caracciolo M, Cattaneo M, DE Servi S.

J Thromb Haemost. 2011 Nov;9(11):2133-42. doi: 10.1111/j.1538-7836.2011.04456.x. Review.

18.

Leber's hereditary optic neuropathy associated with a multiple-sclerosis-like picture in a man.

La Russa A, Cittadella R, Andreoli V, Valentino P, Trecroci F, Caracciolo M, Gallo O, Gambardella A, Quattrone A.

Mult Scler. 2011 Jun;17(6):763-6. doi: 10.1177/1352458511404033.

PMID:
21685233
19.

[The PLATO study].

Caracciolo M, Ardissino D, De Servi S, D'Urbano M.

G Ital Cardiol (Rome). 2010 May;11(5):351-6. Italian. No abstract available.

PMID:
20860154
20.

Urgent surgery in patients with a recently implanted coronary drug-eluting stent: a phase II study of 'bridging' antiplatelet therapy with tirofiban during temporary withdrawal of clopidogrel.

Savonitto S, D'Urbano M, Caracciolo M, Barlocco F, Mariani G, Nichelatti M, Klugmann S, De Servi S.

Br J Anaesth. 2010 Mar;104(3):285-91. doi: 10.1093/bja/aep373. Epub 2010 Jan 3.

21.

[Diagnosis and treatment of non-ST-elevation acute coronary syndromes. Common clinical lessons and a few differences between the ESC and the ACC/AHA guidelines published in 2007].

Savonitto S, Caracciolo M, Sacco A, Klugmann S.

G Ital Cardiol (Rome). 2008 May;9(5):314-9. Italian. No abstract available.

PMID:
18678223
22.

A phenotypic variation of dominant optic atrophy and deafness (ADOAD) due to a novel OPA1 mutation.

Liguori M, La Russa A, Manna I, Andreoli V, Caracciolo M, Spadafora P, Cittadella R, Quattrone A.

J Neurol. 2008 Jan;255(1):127-9. doi: 10.1007/s00415-008-0571-x. Epub 2008 Jan 22. No abstract available.

PMID:
18204809
23.

[Physical exercise and sport activities in patients with and without coronary heart disease].

Francavilla G, Abrignani MG, Braschi A, Sciacca R, Francavilla VC, Caracciolo MM, Renda N, Riccio C, Scaglione A, Braschi G.

Monaldi Arch Chest Dis. 2007 Jun;68(2):87-95. Italian.

PMID:
17886769
24.

[Editorial comment on the British guideline for arterial hypertension, 2006: "Hypertension: management of hypertension in adults in primary care partial update" ].

Riccio C, Caracciolo MM, Abrignani MG.

Monaldi Arch Chest Dis. 2006 Dec;66(4):238-40. Review. Italian. No abstract available.

PMID:
17312841
25.

DJ-1 mutations and parkinsonism-dementia-amyotrophic lateral sclerosis complex.

Annesi G, Savettieri G, Pugliese P, D'Amelio M, Tarantino P, Ragonese P, La Bella V, Piccoli T, Civitelli D, Annesi F, Fierro B, Piccoli F, Arabia G, Caracciolo M, Cirò Candiano IC, Quattrone A.

Ann Neurol. 2005 Nov;58(5):803-7.

PMID:
16240358
26.

Could mitochondrial haplogroups play a role in sporadic amyotrophic lateral sclerosis?

Mancuso M, Conforti FL, Rocchi A, Tessitore A, Muglia M, Tedeschi G, Panza D, Monsurrò M, Sola P, Mandrioli J, Choub A, DelCorona A, Manca ML, Mazzei R, Sprovieri T, Filosto M, Salviati A, Valentino P, Bono F, Caracciolo M, Simone IL, La Bella V, Majorana G, Siciliano G, Murri L, Quattrone A.

Neurosci Lett. 2004 Nov 23;371(2-3):158-62.

PMID:
15519748
27.

Further evidence of genetic heterogeneity in autosomal dominant distal motor neuronopathy.

Passamonti L, Muglia M, Magariello A, Bellesi M, Conforti FL, Mazzei R, Patitucci A, Gabriele AL, Sprovieri T, Peluso G, Caracciolo M, Medici E, Logullo F, Provinciali L, Quattrone A.

Neuromuscul Disord. 2004 Nov;14(11):705-10.

PMID:
15482954
28.

FRAXE intermediate alleles are associated with Parkinson's disease.

Annesi G, Nicoletti G, Tarantino P, Cutuli N, Annesi F, Marco EV, Zappia M, Morgante L, Arabia G, Pugliese P, Condino F, Carrideo S, Civitelli D, Caracciolo M, Romeo N, Spadafora P, Candiano IC, Quattrone A.

Neurosci Lett. 2004 Sep 16;368(1):21-4.

PMID:
15342126
29.

Safety of sentinel node biopsy in pregnant patients with breast cancer.

Gentilini O, Cremonesi M, Trifirò G, Ferrari M, Baio SM, Caracciolo M, Rossi A, Smeets A, Galimberti V, Luini A, Tosi G, Paganelli G.

Ann Oncol. 2004 Sep;15(9):1348-51.

30.

A novel Notch3 gene mutation not involving a cysteine residue in an Italian family with CADASIL.

Mazzei R, Conforti FL, Lanza PL, Sprovieri T, Lupo MR, Gallo O, Patitucci A, Magariello A, Caracciolo M, Gabriele AL, Fera F, Valentino P, Bono F, Cenacchi G, Santoro G, Muglia M, Quattrone A.

Neurology. 2004 Aug 10;63(3):561-4.

PMID:
15304596
31.

Association of tau gene polymorphism with Parkinson's disease.

Zappia M, Annesi G, Nicoletti G, Serra P, Arabia G, Pugliese P, Messina D, Caracciolo M, Romeo N, Annesi F, Pasqua AA, Spadafora P, Civitelli D, Romeo N, Epifanio A, Morgante L, Quattrone A.

Neurol Sci. 2003 Oct;24(3):223-4.

PMID:
14600827
32.

Receptor-mediated radionuclide therapy with 90Y-DOTATOC in association with amino acid infusion: a phase I study.

Bodei L, Cremonesi M, Zoboli S, Grana C, Bartolomei M, Rocca P, Caracciolo M, Mäcke HR, Chinol M, Paganelli G.

Eur J Nucl Med Mol Imaging. 2003 Feb;30(2):207-16. Epub 2002 Nov 16.

PMID:
12552338
33.

Body weight, levodopa pharmacokinetics and dyskinesia in Parkinson's disease.

Arabia G, Zappia M, Bosco D, Crescibene L, Bagalà A, Bastone L, Caracciolo M, Scornaienghi M, Quattrone A.

Neurol Sci. 2002 Sep;23 Suppl 2:S53-4.

PMID:
12548340
34.

A large family with pure autosomal dominant hereditary spastic paraplegia from southern Italy mapping to chromosome 14q11.2-q24.3.

Muglia M, Magariello A, Nicoletti G, Patitucci A, Gabriele AL, Conforti FL, Mazzei R, Caracciolo M, Casari G, Ardito B, Lastilla M, Gambardella A, Quattrone A.

J Neurol. 2002 Oct;249(10):1413-6.

PMID:
12382159
35.

No evidence of association between the alpha-2 macroglobulin gene and Parkinson's disease in a case-control sample.

Nicoletti G, Annesi G, Tomaino C, Spadafora P, Pasqua AA, Annesi F, Serra P, Caracciolo M, Messina D, Zappia M, Quattrone A.

Neurosci Lett. 2002 Aug 2;328(1):65-7.

PMID:
12123860
36.

Further evidence that SPG3A gene mutations cause autosomal dominant hereditary spastic paraplegia.

Muglia M, Magariello A, Nicoletti G, Patitucci A, Gabriele AL, Conforti FL, Mazzei R, Caracciolo M, Ardito B, Lastilla M, Tedeschi G, Quattrone A.

Ann Neurol. 2002 Jun;51(6):794-5. No abstract available.

PMID:
12112092
37.

Anti-GM1 ganglioside antibodies in Parkinson's disease.

Zappia M, Crescibene L, Bosco D, Arabia G, Nicoletti G, Bagalà A, Bastone L, Napoli ID, Caracciolo M, Bonavita S, Di Costanzo A, Gambardella A, Quattrone A.

Acta Neurol Scand. 2002 Jul;106(1):54-7.

PMID:
12067330
38.

Body weight influences pharmacokinetics of levodopa in Parkinson's disease.

Zappia M, Crescibene L, Arabia G, Nicoletti G, Bagalà A, Bastone L, Caracciolo M, Bonavita S, Di Costanzo A, Scornaienchi M, Gambardella A, Quattrone A.

Clin Neuropharmacol. 2002 Mar-Apr;25(2):79-82.

PMID:
11981233
39.

Association of the 5-HT6 receptor gene polymorphism C267T with Parkinson's disease.

Messina D, Annesi G, Serra P, Nicoletti G, Pasqua A, Annesi F, Tomaino C, Cirò-Candiano IC, Carrideo S, Caracciolo M, Spadafora P, Zappia M, Savettieri G, Quattrone A.

Neurology. 2002 Mar 12;58(5):828-9. No abstract available.

PMID:
11889255
40.

Plasma levels of vitamin E in Parkinson's disease.

Nicoletti G, Crescibene L, Scornaienchi M, Bastone L, Bagalà A, Napoli ID, Caracciolo M, Quattrone A.

Arch Gerontol Geriatr. 2001 Aug;33(1):7-12.

PMID:
11461717
41.

Schistosoma mansoni: immunodiagnosis is improved by sodium metaperiodate which reduces cross-reactivity due to glycosylated epitopes of soluble egg antigen.

Alarcón de Noya B, Colmenares C, Lanz H, Caracciolo MA, Losada S, Noya O.

Exp Parasitol. 2000 Jun;95(2):106-12.

PMID:
10910711
42.

The long-duration response to L-dopa in the treatment of early PD.

Zappia M, Oliveri RL, Bosco D, Nicoletti G, Branca D, Caracciolo M, Napoli ID, Gambardella A, Quattrone A.

Neurology. 2000 May 23;54(10):1910-5.

PMID:
10822428
43.

The dopamine D2 receptor gene is a susceptibility locus for Parkinson's disease.

Oliveri RL, Annesi G, Zappia M, Civitelli D, De Marco EV, Pasqua AA, Annesi F, Spadafora P, Gambardella A, Nicoletti G, Branca D, Caracciolo M, Aguglia U, Quattrone A.

Mov Disord. 2000 Jan;15(1):127-31.

PMID:
10634251
44.

Apolipoprotein E polymorphisms and Parkinson's disease.

Oliveri RL, Nicoletti G, Cittadella R, Manna I, Branca D, Zappia M, Gambardella A, Caracciolo M, Quattrone A.

Neurosci Lett. 1999 Dec 24;277(2):83-6.

PMID:
10624815
45.

APOE and risk of cognitive impairment in multiple sclerosis.

Oliveri RL, Cittadella R, Sibilia G, Manna I, Valentino P, Gambardella A, Aguglia U, Zappia M, Romeo N, Andreoli V, Bono F, Caracciolo M, Quattrone A.

Acta Neurol Scand. 1999 Nov;100(5):290-5.

PMID:
10536914
46.

Phosphorylation and glycosylation of nucleoporins.

Miller MW, Caracciolo MR, Berlin WK, Hanover JA.

Arch Biochem Biophys. 1999 Jul 1;367(1):51-60.

PMID:
10375398
47.

[Realities and perspectives of perinatal care in Sicily. Experience at an outborn neonatal unit].

Distefano G, Sciacca P, Marletta M, Caracciolo MC, Di Stefano GC, Romeo MG.

Pediatr Med Chir. 1996 Mar-Apr;18(2):161-7. Italian.

PMID:
8767578
48.

GH secretion in thalassemia patients with short stature.

DeLuca G, Maggiolini M, Bria M, Caracciolo M, Giorno A, Salerno M, Marsico S, Lanzino M, Brancati C, Andò S.

Horm Res. 1995;44(4):158-63.

PMID:
8522276
49.

[Variations of blood bilirubin levels in the newborn with and without retinopathy of prematurity (ROP)].

Romeo MG, Tina LG, Scuderi A, Di Pietro M, Caracciolo M, Distefano G.

Pediatr Med Chir. 1994 Jan-Feb;16(1):59-62. Italian.

PMID:
8029091
50.

[Measurement of the secretion of growth hormone in patients with thalassemia major].

De Luca G, Maggiolini M, Bria M, Caracciolo M, Lanzino M, Le Pera M, Brancati C, Andò S.

Minerva Endocrinol. 1993 Sep;18(3 Suppl 1):62-5. Italian. No abstract available.

PMID:
7910656

Supplemental Content

Loading ...
Support Center